Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122476) titled 'Based on intestinal flora and metabolomics, a prognostic prediction model for patients with decompensated cirrhosis was established and verified' on April 14.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Shenzhen Hospital of Southern Medical Unversity
Condition:
Liver cirrhosis ( LC ) is the final pathological change of liver injury caused by various chronic liver diseases. It is also the main cause of high morbidity and mortality worldwide. About 1 million people die of liver cirrhosis every year worldwide. Cirrhosis is the 11th most common cause of death in the world and the...